Biotechnology
The Biotechnology industry has a total of 645 stocks, with a combined market cap of $818.21 billion and total revenue of $98.24 billion.
Market Cap
818.21B
Revenue
98.24B
Profits
-45.29B
PE Ratio
n/a
Profit Margin
-46.10%
Dividend Yield
0.05%
645 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.31B | -0.15% | 202,076 | 11.10B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 54.95B | -0.05% | 278,999 | 14.09B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.82B | -0.37% | 107,872 | 2.35B |
| 4 | ARGX | argenx SE | 34.30B | 0.15% | 54,962 | 2.64B |
| 5 | ONC | BeOne Medicines Ltd. | 31.09B | -1.91% | 61,775 | 4.18B |
| 6 | BNTX | BioNTech SE | 25.98B | 0.66% | 81,468 | 2.97B |
| 7 | RPRX | Royalty Pharma plc | 19.99B | -1.00% | 502,745 | 2.26B |
| 8 | INSM | Insmed Incorporated | 19.68B | -1.18% | 571,364 | 381.03M |
| 9 | SMMT | Summit Therapeutics Inc. | 15.97B | 1.08% | 331,035 | - |
| 10 | INCY | Incyte Corporation | 13.72B | 4.96% | 1,024,058 | 4.41B |
| 11 | GMAB | Genmab A/S | 12.63B | 0.95% | 106,538 | 3.23B |
| 12 | EXEL | Exelixis, Inc. | 11.83B | -0.32% | 454,004 | 2.30B |
| 13 | MRNA | Moderna, Inc. | 10.53B | 1.41% | 1,429,502 | 3.18B |
| 14 | ASND | Ascendis Pharma A/S | 10.51B | 0.60% | 61,641 | 398.51M |
| 15 | BMRN | BioMarin Pharmaceutical Inc. | 10.46B | 0.70% | 179,102 | 2.95B |
| 16 | VRNA | Verona Pharma plc | 8.66B | -0.12% | 192,714 | 118.54M |
| 17 | BBIO | BridgeBio Pharma, Inc. | 8.43B | -0.02% | 433,926 | 127.42M |
| 18 | TECH | Bio-Techne Corporation | 8.36B | 2.74% | 443,227 | 1.21B |
| 19 | BPMC | Blueprint Medicines Corporation | 8.30B | -0.03% | 533,050 | 562.12M |
| 20 | ROIV | Roivant Sciences Ltd. | 7.78B | 0.44% | 1,315,748 | 29.05M |
| 21 | CORT | Corcept Therapeutics Incorporated | 7.75B | -1.28% | 113,076 | 685.45M |
| 22 | CAI | Caris Life Sciences, Inc. | 7.49B | 1.93% | 142,061 | 452.50M |
| 23 | RVMD | Revolution Medicines, Inc. | 7.10B | -0.76% | 303,215 | - |
| 24 | JAZZ | Jazz Pharmaceuticals plc | 6.52B | 0.64% | 119,231 | 4.06B |
| 25 | HALO | Halozyme Therapeutics, Inc. | 6.51B | 0.92% | 416,775 | 1.08B |
| 26 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.50B | 5.41% | 72,572 | 317.38M |
| 27 | IONS | Ionis Pharmaceuticals, Inc. | 6.39B | 0.40% | 206,705 | 717.25M |
| 28 | LEGN | Legend Biotech Corporation | 6.17B | 0.16% | 123,080 | 728.30M |
| 29 | NUVL | Nuvalent, Inc. | 5.68B | 0.05% | 48,646 | - |
| 30 | TLX | Telix Pharmaceuticals Limited | 5.43B | 3.75% | 10,546 | 484.69M |
| 31 | TGTX | TG Therapeutics, Inc. | 5.41B | -0.40% | 193,342 | 386.39M |
| 32 | AXSM | Axsome Therapeutics, Inc. | 5.10B | -0.46% | 3,814 | 432.16M |
| 33 | AKRO | Akero Therapeutics, Inc. | 4.41B | 0.62% | 165,206 | - |
| 34 | ADMA | ADMA Biologics, Inc. | 4.32B | 2.90% | 427,099 | 459.38M |
| 35 | SLNO | Soleno Therapeutics, Inc. | 4.30B | -0.58% | 209,208 | - |
| 36 | CRSP | CRISPR Therapeutics AG | 4.27B | -2.45% | 892,311 | 37.68M |
| 37 | PCVX | Vaxcyte, Inc. | 4.20B | -1.72% | 163,408 | - |
| 38 | KRYS | Krystal Biotech, Inc. | 4.09B | -0.65% | 27,163 | 333.45M |
| 39 | ZLAB | Zai Lab Limited | 4.01B | -1.87% | 99,994 | 418.33M |
| 40 | MRUS | Merus N.V. | 4.00B | -0.40% | 51,385 | 54.73M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 3.97B | 0.27% | 99,696 | 136.86M |
| 42 | CYTK | Cytokinetics, Incorporated | 3.97B | 0.36% | 132,031 | 19.22M |
| 43 | PTCT | PTC Therapeutics, Inc. | 3.91B | 0.97% | 71,546 | 1.77B |
| 44 | ACAD | ACADIA Pharmaceuticals Inc. | 3.80B | 0.93% | 475,966 | 996.28M |
| 45 | RNA | Avidity Biosciences, Inc. | 3.56B | -1.14% | 104,244 | 8.93M |
| 46 | ACLX | Arcellx, Inc. | 3.55B | 0.47% | 57,431 | 76.81M |
| 47 | SWTX | SpringWorks Therapeutics, Inc. | 3.54B | 0.04% | 726,444 | 219.67M |
| 48 | RARE | Ultragenyx Pharmaceutical Inc. | 3.50B | -0.83% | 126,971 | 590.69M |
| 49 | AAPG | Ascentage Pharma Group International | 3.46B | 0.73% | 6,384 | 134.35M |
| 50 | PTGX | Protagonist Therapeutics, Inc. | 3.42B | 1.29% | 191,197 | 207.80M |
| 51 | SRRK | Scholar Rock Holding Corporation | 3.40B | -0.08% | 167,796 | - |
| 52 | VKTX | Viking Therapeutics, Inc. | 3.20B | 5.28% | 1,443,192 | - |
| 53 | MLTX | MoonLake Immunotherapeutics | 2.96B | -1.48% | 179,230 | - |
| 54 | KYMR | Kymera Therapeutics, Inc. | 2.93B | -3.34% | 363,391 | 58.89M |
| 55 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.82B | -0.95% | 69,512 | 760.00K |
| 56 | MTSR | Metsera, Inc. | 2.78B | -0.71% | 97,426 | - |
| 57 | IMVT | Immunovant, Inc. | 2.73B | 1.52% | 102,489 | - |
| 58 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.67B | 1.53% | 188,293 | 534.65M |
| 59 | APGE | Apogee Therapeutics, Inc. | 2.51B | 0.02% | 40,532 | - |
| 60 | MIRM | Mirum Pharmaceuticals, Inc. | 2.49B | 0.40% | 44,861 | 379.25M |
| 61 | IBRX | ImmunityBio, Inc. | 2.48B | 1.63% | 1,197,422 | 31.22M |
| 62 | XENE | Xenon Pharmaceuticals Inc. | 2.44B | -0.06% | 86,473 | 7.50M |
| 63 | APLS | Apellis Pharmaceuticals, Inc. | 2.30B | -0.65% | 93,002 | 775.84M |
| 64 | LGND | Ligand Pharmaceuticals Incorporated | 2.23B | 0.07% | 18,249 | 181.49M |
| 65 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.15B | -0.77% | 132,521 | 545.21M |
| 66 | DNLI | Denali Therapeutics Inc. | 2.12B | 0.83% | 134,085 | - |
| 67 | VCEL | Vericel Corporation | 2.10B | -0.23% | 28,864 | 238.54M |
| 68 | RXRX | Recursion Pharmaceuticals, Inc. | 2.08B | -1.16% | 6,024,954 | 59.79M |
| 69 | NAMS | NewAmsterdam Pharma Company N.V. | 2.05B | -0.27% | 128,136 | 47.14M |
| 70 | BLTE | Belite Bio, Inc | 1.98B | -0.57% | 13,284 | - |
| 71 | CGON | CG Oncology, Inc. | 1.98B | -0.48% | 88,283 | 662.00K |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 1.94B | 0.64% | 225,513 | 7.00M |
| 73 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | 0.46% | 32,822 | 37.04M |
| 74 | IRON | Disc Medicine, Inc. | 1.85B | -1.14% | 23,740 | - |
| 75 | ADPT | Adaptive Biotechnologies Corporation | 1.84B | 0.92% | 1,603,068 | 189.53M |
| 76 | GLPG | Galapagos NV | 1.83B | 1.55% | 22,507 | 311.49M |
| 77 | HRMY | Harmony Biosciences Holdings, Inc. | 1.82B | 0.57% | 46,325 | 744.85M |
| 78 | FOLD | Amicus Therapeutics, Inc. | 1.74B | -0.09% | 379,234 | 543.14M |
| 79 | SPRY | ARS Pharmaceuticals, Inc. | 1.73B | 2.20% | 188,302 | 97.12M |
| 80 | CNTA | Centessa Pharmaceuticals plc | 1.73B | -3.57% | 62,396 | 15.00M |
| 81 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | 0.46% | 1,986,923 | 2.23B |
| 82 | ARQT | Arcutis Biotherapeutics, Inc. | 1.72B | -0.28% | 240,822 | 212.82M |
| 83 | TARS | Tarsus Pharmaceuticals, Inc. | 1.69B | -0.05% | 54,708 | 233.67M |
| 84 | BEAM | Beam Therapeutics Inc. | 1.65B | 1.01% | 296,920 | 63.58M |
| 85 | IMCR | Immunocore Holdings plc | 1.63B | 1.47% | 39,094 | 333.58M |
| 86 | BHVN | Biohaven Ltd. | 1.47B | 0.35% | 283,166 | - |
| 87 | VERA | Vera Therapeutics, Inc. | 1.47B | -1.33% | 823,434 | - |
| 88 | OCUL | Ocular Therapeutix, Inc. | 1.46B | -0.11% | 299,170 | 59.65M |
| 89 | ETNB | 89bio, Inc. | 1.43B | 0.61% | 74,304 | - |
| 90 | CLDX | Celldex Therapeutics, Inc. | 1.39B | -2.38% | 70,811 | 7.56M |
| 91 | JANX | Janux Therapeutics, Inc. | 1.38B | 0.04% | 40,452 | 9.34M |
| 92 | EWTX | Edgewise Therapeutics, Inc. | 1.35B | -10.26% | 1,287,394 | - |
| 93 | MESO | Mesoblast Limited | 1.34B | 2.09% | 9,124 | 5.67M |
| 94 | TVTX | Travere Therapeutics, Inc. | 1.33B | -0.03% | 65,566 | 273.53M |
| 95 | INVA | Innoviva, Inc. | 1.29B | 0.44% | 38,750 | 369.84M |
| 96 | ELVN | Enliven Therapeutics, Inc. | 1.24B | -1.95% | 72,980 | - |
| 97 | GPCR | Structure Therapeutics Inc. | 1.23B | -2.02% | 51,146 | - |
| 98 | CVAC | CureVac N.V. | 1.22B | -0.46% | 239,127 | 566.04M |
| 99 | VRDN | Viridian Therapeutics, Inc. | 1.18B | -1.56% | 53,555 | 302.00K |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.18B | 8.59% | 1,463,774 | 247.30M |
| 101 | DYN | Dyne Therapeutics, Inc. | 1.16B | -1.78% | 284,455 | - |
| 102 | MNKD | MannKind Corporation | 1.15B | -2.08% | 317,772 | 297.60M |
| 103 | LQDA | Liquidia Corporation | 1.12B | -3.46% | 400,420 | 14.14M |
| 104 | ABCL | AbCellera Biologics Inc. | 1.12B | -1.05% | 1,735,622 | 23.11M |
| 105 | NAGE | Niagen Bioscience, Inc. | 1.06B | 0.41% | 150,811 | 107.93M |
| 106 | OCS | Oculis Holding AG | 1.06B | 0.21% | 2,537 | 847.33K |
| 107 | WVE | Wave Life Sciences Ltd. | 1.05B | -0.58% | 149,118 | 104.94M |
| 108 | NVAX | Novavax, Inc. | 1.05B | -0.31% | 1,017,813 | 1.25B |
| 109 | CRMD | CorMedix Inc. | 1.01B | -0.80% | 203,906 | 82.55M |
| 110 | VERV | Verve Therapeutics, Inc. | 1.00B | -0.04% | 1,724,830 | 59.61M |
| 111 | NTLA | Intellia Therapeutics, Inc. | 998.03M | 0.78% | 750,173 | 45.57M |
| 112 | PHVS | Pharvaris N.V. | 951.18M | -0.60% | 3,542 | - |
| 113 | SYRE | Spyre Therapeutics, Inc. | 949.66M | 0.10% | 31,146 | - |
| 114 | GERN | Geron Corporation | 949.01M | -1.97% | 1,518,449 | 116.29M |
| 115 | MLYS | Mineralys Therapeutics, Inc. | 924.51M | -0.39% | 91,353 | - |
| 116 | RCUS | Arcus Biosciences, Inc. | 911.67M | -0.12% | 45,566 | 141.00M |
| 117 | ORIC | ORIC Pharmaceuticals, Inc. | 885.48M | 1.56% | 149,601 | - |
| 118 | NRIX | Nurix Therapeutics, Inc. | 882.43M | -0.39% | 34,958 | 56.42M |
| 119 | ZYME | Zymeworks Inc. | 881.50M | -0.47% | 32,712 | 93.38M |
| 120 | MDXG | MiMedx Group, Inc. | 878.83M | -0.17% | 38,757 | 352.38M |
| 121 | ARDX | Ardelyx, Inc. | 872.09M | 0.41% | 428,179 | 361.71M |
| 122 | PRAX | Praxis Precision Medicines, Inc. | 860.18M | -2.54% | 14,415 | 8.12M |
| 123 | COGT | Cogent Biosciences, Inc. | 831.15M | 3.18% | 372,315 | - |
| 124 | LENZ | LENZ Therapeutics, Inc. | 827.92M | -0.36% | 13,077 | - |
| 125 | AVXL | Anavex Life Sciences Corp. | 808.47M | 0.64% | 55,063 | - |
| 126 | QURE | uniQure N.V. | 804.80M | 2.58% | 114,904 | 20.20M |
| 127 | SNDX | Syndax Pharmaceuticals, Inc. | 794.22M | 3.71% | 911,592 | 43.72M |
| 128 | AVBP | ArriVent BioPharma, Inc. | 775.26M | -0.61% | 53,263 | - |
| 129 | XERS | Xeris Biopharma Holdings, Inc. | 754.33M | - | 198,764 | 222.55M |
| 130 | GHRS | GH Research PLC | 753.95M | 2.23% | 26,372 | - |
| 131 | PHAR | Pharming Group N.V. | 742.30M | -0.32% | 169 | 320.71M |
| 132 | IMNM | Immunome, Inc. | 739.60M | -2.07% | 81,038 | 10.94M |
| 133 | REPL | Replimune Group, Inc. | 726.16M | -0.32% | 133,038 | - |
| 134 | VIR | Vir Biotechnology, Inc. | 714.69M | -0.39% | 68,382 | 20.86M |
| 135 | EYPT | EyePoint Pharmaceuticals, Inc. | 703.26M | -3.04% | 327,108 | 56.04M |
| 136 | ANAB | AnaptysBio, Inc. | 684.86M | 0.30% | 67,213 | 111.87M |
| 137 | GYRE | Gyre Therapeutics, Inc. | 679.92M | 1.21% | 57,075 | 100.64M |
| 138 | TRVI | Trevi Therapeutics, Inc. | 674.96M | -0.26% | 163,487 | - |
| 139 | IMTX | Immatics N.V. | 663.66M | - | 204,254 | 155.80M |
| 140 | SION | Sionna Therapeutics, Inc. | 663.37M | 0.50% | 11,970 | - |
| 141 | PHAT | Phathom Pharmaceuticals, Inc. | 660.27M | -1.04% | 152,022 | 81.86M |
| 142 | DAWN | Day One Biopharmaceuticals, Inc. | 649.73M | -0.47% | 117,785 | 161.92M |
| 143 | SANA | Sana Biotechnology, Inc. | 646.22M | -1.21% | 433,614 | - |
| 144 | CDTX | Cidara Therapeutics, Inc. | 629.17M | -1.66% | 304,832 | 302.00K |
| 145 | STOK | Stoke Therapeutics, Inc. | 626.77M | -2.79% | 104,088 | 190.91M |
| 146 | NUVB | Nuvation Bio Inc. | 626.08M | -2.13% | 1,791,613 | 10.96M |
| 147 | ABUS | Arbutus Biopharma Corporation | 624.38M | -2.40% | 121,502 | 6.40M |
| 148 | RGLS | Regulus Therapeutics Inc. | 616.99M | 0.25% | 9,342,413 | - |
| 149 | AUTL | Autolus Therapeutics plc | 612.13M | -0.86% | 331,195 | 9.01M |
| 150 | URGN | UroGen Pharma Ltd. | 603.09M | -4.66% | 550,414 | 91.87M |
| 151 | XNCR | Xencor, Inc. | 602.10M | -1.17% | 28,706 | 127.23M |
| 152 | MRVI | Maravai LifeSciences Holdings, Inc. | 599.72M | 3.74% | 530,089 | 241.86M |
| 153 | UPB | Upstream Bio, Inc. | 588.23M | 0.41% | 28,444 | 2.30M |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 587.24M | -0.44% | 14,475 | 6.52M |
| 155 | IOVA | Iovance Biotherapeutics, Inc. | 579.38M | -2.53% | 3,397,447 | 212.68M |
| 156 | SAGE | Sage Therapeutics, Inc. | 576.75M | -0.43% | 186,352 | 47.40M |
| 157 | ARVN | Arvinas, Inc. | 570.06M | 0.13% | 165,646 | 426.90M |
| 158 | AMLX | Amylyx Pharmaceuticals, Inc. | 568.72M | 1.92% | 241,912 | -1.27M |
| 159 | KALV | KalVista Pharmaceuticals, Inc. | 565.27M | -2.65% | 191,655 | - |
| 160 | DNA | Ginkgo Bioworks Holdings, Inc. | 559.27M | 2.52% | 304,544 | 237.42M |
| 161 | RLAY | Relay Therapeutics, Inc. | 557.20M | -0.31% | 82,807 | 7.68M |
| 162 | KROS | Keros Therapeutics, Inc. | 552.78M | -0.29% | 37,835 | 214.71M |
| 163 | TNGX | Tango Therapeutics, Inc. | 539.80M | 0.20% | 362,871 | 40.99M |
| 164 | TBPH | Theravance Biopharma, Inc. | 535.01M | 1.13% | 19,322 | 65.27M |
| 165 | MGTX | MeiraGTx Holdings plc | 528.00M | 0.46% | 59,587 | 34.51M |
| 166 | TSHA | Taysha Gene Therapies, Inc. | 521.63M | -0.41% | 334,087 | 7.22M |
| 167 | MAZE | Maze Therapeutics, Inc. | 519.87M | 4.03% | 21,194 | 167.50M |
| 168 | MNMD | Mind Medicine (MindMed) Inc. | 511.87M | -0.95% | 194,215 | - |
| 169 | TYRA | Tyra Biosciences, Inc. | 509.71M | -0.47% | 13,839 | - |
| 170 | ZVRA | Zevra Therapeutics, Inc. | 503.05M | -1.39% | 65,678 | 40.59M |
| 171 | KURA | Kura Oncology, Inc. | 502.13M | - | 104,935 | 67.99M |
| 172 | BCYC | Bicycle Therapeutics plc | 493.09M | 0.28% | 60,530 | 25.72M |
| 173 | SEPN | Septerna, Inc. | 492.82M | 3.08% | 70,769 | 977.00K |
| 174 | BCAX | Bicara Therapeutics Inc. | 491.37M | 0.78% | 181,800 | - |
| 175 | LIMN | Liminatus Pharma, Inc. | 486.47M | -22.02% | 68,948 | - |
| 176 | FTRE | Fortrea Holdings Inc. | 485.30M | 3.38% | 136,010 | 2.69B |
| 177 | ATYR | aTyr Pharma, Inc. | 468.61M | 3.03% | 987,012 | 235.00K |
| 178 | OPT | Opthea Limited | 466.57M | - | - | 208.86K |
| 179 | CGEM | Cullinan Therapeutics, Inc. | 465.92M | -0.32% | 15,610 | - |
| 180 | VALN | Valneva SE | 464.26M | 1.87% | 2,037 | 201.10M |
| 181 | SVRA | Savara Inc. | 457.20M | -0.91% | 53,141 | - |
| 182 | CAPR | Capricor Therapeutics, Inc. | 452.51M | -1.49% | 511,281 | 17.36M |
| 183 | ATAI | Atai Life Sciences N.V. | 441.50M | -0.04% | 403,608 | 1.86M |
| 184 | CELC | Celcuity Inc. | 440.76M | -1.77% | 13,680 | - |
| 185 | MREO | Mereo BioPharma Group plc | 438.05M | -1.25% | 140,588 | 1.00M |
| 186 | RAPP | Rapport Therapeutics, Inc. | 436.51M | 1.96% | 5,433 | - |
| 187 | TRML | Tourmaline Bio, Inc. | 436.45M | - | 14,880 | - |
| 188 | ORKA | Oruka Therapeutics, Inc. | 435.06M | -0.09% | 17,575 | - |
| 189 | ZBIO | Zenas BioPharma, Inc. | 431.52M | 1.23% | 15,909 | 15.00M |
| 190 | RGNX | REGENXBIO Inc. | 430.32M | - | 49,344 | 156.72M |
| 191 | IVA | Inventiva S.A. | 428.14M | 0.98% | 139 | 14.59M |
| 192 | ABVX | ABIVAX Société Anonyme | 427.90M | 0.14% | 80,092 | 11.44M |
| 193 | PGEN | Precigen, Inc. | 423.58M | 1.06% | 229,573 | 4.20M |
| 194 | PRTC | PureTech Health plc | 407.09M | 3.47% | 704 | 4.83M |
| 195 | AURA | Aura Biosciences, Inc. | 401.17M | -1.52% | 10,615 | - |
| 196 | FULC | Fulcrum Therapeutics, Inc. | 387.57M | 0.28% | 44,852 | 80.00M |
| 197 | NKTR | Nektar Therapeutics | 384.61M | 6.46% | 3,549,989 | 87.25M |
| 198 | ITOS | iTeos Therapeutics, Inc. | 383.89M | -0.10% | 107,789 | 35.00M |
| 199 | ERAS | Erasca, Inc. | 383.85M | -1.81% | 81,680 | - |
| 200 | ARCT | Arcturus Therapeutics Holdings Inc. | 378.33M | - | 51,494 | 143.68M |
| 201 | MBX | MBX Biosciences, Inc. | 377.70M | -5.12% | 204,214 | - |
| 202 | SLDB | Solid Biosciences Inc. | 371.69M | 1.16% | 512,244 | - |
| 203 | RZLT | Rezolute, Inc. | 371.15M | 0.23% | 145,368 | - |
| 204 | VIGL | Vigil Neuroscience, Inc. | 371.04M | - | 59,685 | - |
| 205 | TECX | Tectonic Therapeutic, Inc. | 369.94M | -2.64% | 6,356 | - |
| 206 | BNTC | Benitec Biopharma Inc. | 357.16M | 3.39% | 25,695 | - |
| 207 | CMPX | Compass Therapeutics, Inc. | 356.77M | -4.09% | 149,542 | 850.00K |
| 208 | TERN | Terns Pharmaceuticals, Inc. | 355.46M | 0.25% | 221,561 | - |
| 209 | CTMX | CytomX Therapeutics, Inc. | 355.26M | 2.04% | 299,518 | 147.56M |
| 210 | ABSI | Absci Corporation | 346.96M | -1.45% | 1,166,447 | 4.82M |
| 211 | HUMA | Humacyte, Inc. | 342.81M | 0.91% | 362,941 | 517.00K |
| 212 | LXRX | Lexicon Pharmaceuticals, Inc. | 333.32M | 2.15% | 1,882,742 | 31.21M |
| 213 | HRTX | Heron Therapeutics, Inc. | 331.83M | 1.16% | 138,670 | 148.52M |
| 214 | XOMA | XOMA Royalty Corporation | 331.12M | 0.80% | 921 | 42.91M |
| 215 | RIGL | Rigel Pharmaceuticals, Inc. | 330.82M | -0.64% | 23,352 | 203.08M |
| 216 | JBIO | Jade Biosciences, Inc. | 323.97M | -4.38% | 30,399 | - |
| 217 | PRTA | Prothena Corporation plc | 319.19M | -1.00% | 238,859 | 137.94M |
| 218 | OLMA | Olema Pharmaceuticals, Inc. | 318.16M | -2.11% | 115,752 | - |
| 219 | AARD | Aardvark Therapeutics, Inc. | 314.81M | -5.66% | 23,851 | - |
| 220 | CRVS | Corvus Pharmaceuticals, Inc. | 311.54M | -1.94% | 121,246 | - |
| 221 | PRME | Prime Medicine, Inc. | 309.33M | - | 694,226 | 3.85M |
| 222 | ATXS | Astria Therapeutics, Inc. | 307.57M | -3.54% | 45,080 | - |
| 223 | AVIR | Atea Pharmaceuticals, Inc. | 304.66M | 2.59% | 113,807 | - |
| 224 | GOSS | Gossamer Bio, Inc. | 304.58M | -1.47% | 217,986 | 124.59M |
| 225 | ABEO | Abeona Therapeutics Inc. | 303.87M | -0.67% | 161,565 | - |
| 226 | OCGN | Ocugen, Inc. | 303.71M | - | 1,239,889 | 4.52M |
| 227 | RNAC | Cartesian Therapeutics, Inc. | 291.99M | 4.55% | 19,913 | 34.17M |
| 228 | ALT | Altimmune, Inc. | 289.55M | -53.70% | 57,477,127 | 20.00K |
| 229 | GLUE | Monte Rosa Therapeutics, Inc. | 287.25M | -2.10% | 61,221 | 159.49M |
| 230 | CBIO | Crescent Biopharma, Inc. | 282.48M | 4.94% | 39,165 | - |
| 231 | RCKT | Rocket Pharmaceuticals, Inc. | 281.20M | -1.51% | 604,361 | - |
| 232 | SGMT | Sagimet Biosciences Inc. | 279.78M | -3.55% | 371,918 | - |
| 233 | FHTX | Foghorn Therapeutics Inc. | 276.48M | 1.22% | 6,393 | 23.50M |
| 234 | VNDA | Vanda Pharmaceuticals Inc. | 275.81M | 1.52% | 140,585 | 201.35M |
| 235 | SLN | Silence Therapeutics plc | 269.92M | -1.47% | 15,807 | 27.70M |
| 236 | ALLO | Allogene Therapeutics, Inc. | 266.85M | -1.61% | 433,485 | 22.00K |
| 237 | DRTS | Alpha Tau Medical Ltd. | 266.80M | 5.00% | 30,202 | - |
| 238 | ADCT | ADC Therapeutics SA | 263.81M | -3.62% | 341,000 | 75.82M |
| 239 | ANNX | Annexon, Inc. | 263.31M | 0.42% | 131,717 | - |
| 240 | TENX | Tenax Therapeutics, Inc. | 259.99M | 7.73% | 7,610 | - |
| 241 | INZY | Inozyme Pharma, Inc. | 259.34M | 0.13% | 80,790 | - |
| 242 | TNXP | Tonix Pharmaceuticals Holding Corp. | 255.76M | 1.60% | 163,243 | 10.04M |
| 243 | CADL | Candel Therapeutics, Inc. | 252.52M | 3.92% | 165,986 | - |
| 244 | TVRD | Tvardi Therapeutics, Inc. | 252.37M | -0.55% | 1,617 | - |
| 245 | TRDA | Entrada Therapeutics, Inc. | 246.44M | -0.99% | 13,114 | 172.22M |
| 246 | THRD | Third Harmonic Bio, Inc. | 245.71M | 0.46% | 10,645 | - |
| 247 | DBVT | DBV Technologies S.A. | 238.80M | 4.63% | 15,539 | 3.50M |
| 248 | LCTX | Lineage Cell Therapeutics, Inc. | 238.63M | -2.34% | 389,021 | 9.56M |
| 249 | NGNE | Neurogene Inc. | 235.97M | -1.98% | 23,837 | 925.00K |
| 250 | FENC | Fennec Pharmaceuticals Inc. | 233.38M | 0.60% | 6,719 | 30.91M |
| 251 | VSTM | Verastem, Inc. | 232.43M | -1.63% | 404,126 | 10.00M |
| 252 | IMMP | Immutep Limited | 232.24M | 2.50% | 25,869 | 3.02M |
| 253 | PVLA | Palvella Therapeutics, Inc. | 232.06M | -1.64% | 867 | - |
| 254 | LXEO | Lexeo Therapeutics, Inc. | 229.28M | -0.24% | 137,233 | - |
| 255 | PRQR | ProQR Therapeutics N.V. | 225.96M | -0.69% | 141,832 | 21.21M |
| 256 | DSGN | Design Therapeutics, Inc. | 223.10M | -0.51% | 4,394 | - |
| 257 | TVGN | Tevogen Bio Holdings Inc. | 219.21M | 1.58% | 23,972 | - |
| 258 | PROK | ProKidney Corp. | 219.15M | -2.89% | 242,120 | 306.00K |
| 259 | ALDX | Aldeyra Therapeutics, Inc. | 218.62M | 3.99% | 466,055 | - |
| 260 | YMAB | Y-mAbs Therapeutics, Inc. | 218.33M | -1.83% | 34,270 | 88.66M |
| 261 | NBTX | Nanobiotix S.A. | 216.05M | 4.64% | 2,011 | -7.44M |
| 262 | MDWD | MediWound Ltd. | 211.18M | 0.10% | 4,070 | 19.21M |
| 263 | INBX | Inhibrx Biosciences, Inc. | 210.05M | -2.68% | 17,841 | 200.00K |
| 264 | SCPH | scPharmaceuticals Inc. | 208.00M | -0.76% | 14,520 | 41.98M |
| 265 | ACIU | AC Immune SA | 207.30M | 1.21% | 41,018 | 32.01M |
| 266 | CRDF | Cardiff Oncology, Inc. | 206.23M | - | 128,925 | 587.00K |
| 267 | CDXS | Codexis, Inc. | 205.46M | -1.20% | 45,641 | 49.82M |
| 268 | OABI | OmniAb, Inc. | 203.69M | 0.30% | 23,591 | 26.74M |
| 269 | MNPR | Monopar Therapeutics Inc. | 202.17M | 3.57% | 2,513 | - |
| 270 | KOD | Kodiak Sciences Inc. | 199.47M | 2.71% | 64,310 | - |
| 271 | OMER | Omeros Corporation | 196.29M | -4.29% | 205,220 | - |
| 272 | TLSA | Tiziana Life Sciences Ltd | 195.06M | - | 111,223 | - |
| 273 | LRMR | Larimar Therapeutics, Inc. | 193.68M | -6.92% | 264,655 | - |
| 274 | GNFT | Genfit S.A. | 192.56M | 7.76% | 481 | 73.19M |
| 275 | IMAB | I-Mab | 191.09M | -15.83% | 840,877 | 569.46K |
| 276 | CRGX | CARGO Therapeutics, Inc. | 189.99M | -0.48% | 35,561 | - |
| 277 | DRUG | Bright Minds Biosciences Inc. | 188.95M | -3.03% | 7,438 | - |
| 278 | FDMT | 4D Molecular Therapeutics, Inc. | 183.91M | -2.70% | 21,667 | 23.00K |
| 279 | SLS | SELLAS Life Sciences Group, Inc. | 183.09M | -0.81% | 1,369,329 | - |
| 280 | NVCT | Nuvectis Pharma, Inc. | 182.93M | - | 16,457 | - |
| 281 | CYBN | Cybin Inc. | 181.33M | 4.36% | 99,947 | - |
| 282 | EDIT | Editas Medicine, Inc. | 179.98M | -1.83% | 888,555 | 35.84M |
| 283 | VTYX | Ventyx Biosciences, Inc. | 174.70M | 2.29% | 176,982 | - |
| 284 | ACRS | Aclaris Therapeutics, Inc. | 172.71M | -2.15% | 278,883 | 17.78M |
| 285 | ENGN | enGene Holdings Inc. | 169.16M | 1.53% | 28,438 | - |
| 286 | DMAC | DiaMedica Therapeutics Inc. | 168.53M | -0.51% | 21,232 | - |
| 287 | ENGNW | enGene Holdings Inc. | 166.60M | 1.34% | - | - |
| 288 | PBYI | Puma Biotechnology, Inc. | 165.54M | 0.76% | 45,359 | 232.71M |
| 289 | ALMS | Alumis Inc. | 164.30M | 3.07% | 206,970 | 17.39M |
| 290 | ELDN | Eledon Pharmaceuticals, Inc. | 162.88M | -0.73% | 45,283 | - |
| 291 | SPRO | Spero Therapeutics, Inc. | 162.14M | - | 312,410 | 44.58M |
| 292 | IPHA | Innate Pharma S.A. | 162.01M | 0.84% | 250 | 20.83M |
| 293 | TIL | Instil Bio, Inc. | 160.72M | -8.96% | 117,831 | - |
| 294 | VYGR | Voyager Therapeutics, Inc. | 160.48M | -1.36% | 172,201 | 66.96M |
| 295 | GALT | Galectin Therapeutics Inc. | 157.60M | -0.80% | 47,737 | - |
| 296 | CGEN | Compugen Ltd. | 157.16M | -0.56% | 24,158 | 27.59M |
| 297 | EPRX | Eupraxia Pharmaceuticals Inc. | 156.95M | 4.41% | 1,554 | - |
| 298 | ENTA | Enanta Pharmaceuticals, Inc. | 156.90M | -1.48% | 9,768 | 64.46M |
| 299 | RAPT | RAPT Therapeutics, Inc. | 153.45M | -2.93% | 14,213 | - |
| 300 | INMB | INmune Bio, Inc. | 149.94M | -12.35% | 434,433 | 50.00K |
| 301 | ALEC | Alector, Inc. | 148.99M | - | 41,482 | 88.34M |
| 302 | ACOG | Alpha Cognition Inc. | 146.42M | -4.49% | 17,831 | 2.93M |
| 303 | BDTX | Black Diamond Therapeutics, Inc. | 145.00M | -1.54% | 201,264 | 70.00M |
| 304 | MOLN | Molecular Partners AG | 141.64M | 1.33% | 1,021 | 2.53M |
| 305 | SGMO | Sangamo Therapeutics, Inc. | 140.56M | 1.65% | 4,337,323 | 63.76M |
| 306 | AGEN | Agenus Inc. | 137.63M | 1.83% | 159,857 | 99.52M |
| 307 | KYTX | Kyverna Therapeutics, Inc. | 137.44M | 3.58% | 148,544 | - |
| 308 | NMRA | Neumora Therapeutics, Inc. | 136.90M | 4.77% | 141,798 | - |
| 309 | LYEL | Lyell Immunopharma, Inc. | 134.46M | -2.26% | 7,089 | 65.00K |
| 310 | ASMB | Assembly Biosciences, Inc. | 132.17M | -0.03% | 6,892 | 32.15M |
| 311 | MIST | Milestone Pharmaceuticals Inc. | 130.09M | 3.70% | 236,909 | - |
| 312 | FATE | Fate Therapeutics, Inc. | 128.96M | -3.02% | 310,458 | 13.34M |
| 313 | SKYE | Skye Bioscience, Inc. | 128.89M | 12.74% | 646,531 | - |
| 314 | ELTX | Elicio Therapeutics, Inc. | 128.82M | 0.50% | 12,204 | - |
| 315 | ACHV | Achieve Life Sciences, Inc. | 128.33M | -2.63% | 36,327 | - |
| 316 | CUPR | Cuprina Holdings (Cayman) Limited | 127.20M | -5.12% | 3,819 | 35.41K |
| 317 | CRBU | Caribou Biosciences, Inc. | 125.56M | -4.93% | 233,599 | 9.92M |
| 318 | NKTX | Nkarta, Inc. | 124.18M | -1.69% | 38,009 | - |
| 319 | ACTU | Actuate Therapeutics, Inc. | 124.03M | -1.84% | 17,567 | - |
| 320 | IKT | Inhibikase Therapeutics, Inc. | 123.41M | -0.60% | 6,038 | 1.00 |
| 321 | VXRT | Vaxart, Inc. | 120.87M | -1.56% | 349,922 | 47.40M |
| 322 | SEER | Seer, Inc. | 119.16M | -0.25% | 49,972 | 15.31M |
| 323 | GLSI | Greenwich LifeSciences, Inc. | 118.68M | -1.36% | 7,899 | - |
| 324 | OBIO | Orchestra BioMed Holdings, Inc. | 117.24M | -0.97% | 47,393 | 2.89M |
| 325 | PLX | Protalix BioTherapeutics, Inc. | 117.02M | 4.26% | 207,751 | 59.76M |
| 326 | VOR | Vor Biopharma Inc. | 116.96M | 68.83% | 159,860,184 | - |
| 327 | VTVT | vTv Therapeutics Inc. | 116.65M | - | 2 | 17.00K |
| 328 | ATOS | Atossa Therapeutics, Inc. | 116.40M | 4.56% | 510,034 | - |
| 329 | KRRO | Korro Bio, Inc. | 114.14M | 1.80% | 6,570 | 4.82M |
| 330 | TARA | Protara Therapeutics, Inc. | 112.43M | 0.83% | 47,058 | - |
| 331 | THTX | Theratechnologies Inc. | 112.36M | -4.51% | 64,173 | 88.67M |
| 332 | CTNM | Contineum Therapeutics, Inc. | 111.77M | -5.88% | 67,338 | - |
| 333 | TNYA | Tenaya Therapeutics, Inc. | 111.18M | -0.94% | 390,926 | - |
| 334 | IMRX | Immuneering Corporation | 110.12M | 1.32% | 447,370 | - |
| 335 | CCCC | C4 Therapeutics, Inc. | 108.29M | -0.97% | 77,866 | 39.78M |
| 336 | GNLX | Genelux Corporation | 107.62M | -1.87% | 10,098 | 8.00K |
| 337 | CLLS | Cellectis S.A. | 106.74M | -2.33% | 4,109 | 54.75M |
| 338 | NAUT | Nautilus Biotechnology, Inc. | 106.52M | 6.43% | 85,832 | - |
| 339 | BMEA | Biomea Fusion, Inc. | 106.06M | -4.12% | 546,054 | - |
| 340 | ANIX | Anixa Biosciences, Inc. | 105.33M | -1.21% | 38,952 | - |
| 341 | BYSI | BeyondSpring Inc. | 102.81M | 1.59% | 2,154 | 1.88M |
| 342 | VERU | Veru Inc. | 101.33M | -0.53% | 481,216 | 16.89M |
| 343 | IOBT | IO Biotech, Inc. | 100.80M | 1.32% | 30,474 | - |
| 344 | HURA | TuHURA Biosciences, Inc. | 100.46M | 3.14% | 37,757 | - |
| 345 | COYA | Coya Therapeutics, Inc. | 99.68M | 0.68% | 34,936 | 3.69M |
| 346 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 99.48M | -6.23% | 18,967 | - |
| 347 | CSBR | Champions Oncology, Inc. | 98.06M | -5.50% | 9,841 | 58.59M |
| 348 | HLVX | HilleVax, Inc. | 95.49M | 1.32% | 18,952 | - |
| 349 | IVVD | Invivyd, Inc. | 94.12M | 11.40% | 1,338,857 | 36.69M |
| 350 | ZNTL | Zentalis Pharmaceuticals, Inc. | 93.90M | -0.38% | 139,076 | 26.87M |
| 351 | CABA | Cabaletta Bio, Inc. | 93.10M | -1.41% | 223,679 | - |
| 352 | ADAG | Adagene Inc. | 91.86M | 0.52% | 7,535 | 103.20K |
| 353 | OKYO | OKYO Pharma Limited | 91.69M | -0.81% | 16,199 | - |
| 354 | SAVA | Cassava Sciences, Inc. | 89.37M | - | 211,211 | - |
| 355 | ENTX | Entera Bio Ltd. | 89.09M | -0.51% | 883 | 223.00K |
| 356 | ORMP | Oramed Pharmaceuticals Inc. | 88.19M | -0.97% | 15,078 | 2.00M |
| 357 | WHWK | Whitehawk Therapeutics, Inc. | 87.62M | -0.53% | 7,508 | 27.78M |
| 358 | CLYM | Climb Bio, Inc. | 87.51M | -0.38% | 28,568 | - |
| 359 | NTRB | Nutriband Inc. | 85.70M | - | 3,001 | 2.40M |
| 360 | EXOZ | eXoZymes, Inc. | 85.69M | - | - | -700.00 |
| 361 | TCRX | TScan Therapeutics, Inc. | 85.45M | -1.95% | 79,384 | 4.42M |
| 362 | CHRS | Coherus Oncology, Inc. | 85.43M | 2.21% | 327,643 | 272.25M |
| 363 | PLRX | Pliant Therapeutics, Inc. | 84.71M | - | 188,750 | - |
| 364 | GUTS | Fractyl Health, Inc. | 84.24M | -1.15% | 36,235 | 60.00K |
| 365 | XBIT | XBiotech Inc. | 83.54M | 3.01% | 11,745 | - |
| 366 | JSPR | Jasper Therapeutics, Inc. | 83.37M | -0.27% | 22,799 | - |
| 367 | INO | Inovio Pharmaceuticals, Inc. | 82.33M | 1.58% | 299,124 | 283.10K |
| 368 | MCRB | Seres Therapeutics, Inc. | 82.17M | -1.05% | 27,102 | - |
| 369 | MGNX | MacroGenics, Inc. | 82.02M | -0.76% | 171,462 | 154.05M |
| 370 | CBUS | Cibus, Inc. | 81.19M | 1.29% | 86,896 | 4.75M |
| 371 | PYXS | Pyxis Oncology, Inc. | 78.67M | -0.78% | 62,844 | 16.15M |
| 372 | VANI | Vivani Medical, Inc. | 77.61M | 0.77% | 28,441 | - |
| 373 | OTLK | Outlook Therapeutics, Inc. | 77.57M | 0.56% | 106,704 | - |
| 374 | SRZN | Surrozen, Inc. | 77.45M | 3.97% | 344 | 11.64M |
| 375 | UNCY | Unicycive Therapeutics, Inc. | 77.36M | -1.45% | 184,014 | - |
| 376 | EPIX | ESSA Pharma Inc. | 77.01M | -0.29% | 6,896 | - |
| 377 | ABOS | Acumen Pharmaceuticals, Inc. | 75.72M | 1.63% | 47,723 | - |
| 378 | IGMS | IGM Biosciences, Inc. | 75.14M | 3.31% | 9,014 | 2.68M |
| 379 | NTHI | NeOnc Technologies Holdings, Inc. | 74.39M | 5.11% | 4,541 | 79.99K |
| 380 | QNTM | Quantum BioPharma Ltd. | 73.08M | -13.30% | 212,757 | - |
| 381 | ZURA | Zura Bio Limited | 69.92M | -4.24% | 38,689 | - |
| 382 | ARMP | Armata Pharmaceuticals, Inc. | 69.51M | -3.49% | 11,692 | 4.70M |
| 383 | QNCX | Quince Therapeutics, Inc. | 69.34M | -4.69% | 58,855 | - |
| 384 | FBRX | Forte Biosciences, Inc. | 68.80M | -1.32% | 27,704 | - |
| 385 | IMUX | Immunic, Inc. | 68.41M | 1.81% | 493,903 | - |
| 386 | PDSB | PDS Biotechnology Corporation | 67.88M | -1.66% | 132,818 | - |
| 387 | STRO | Sutro Biopharma, Inc. | 66.92M | -1.61% | 193,307 | 66.43M |
| 388 | ANRO | Alto Neuroscience, Inc. | 66.33M | -4.67% | 415,087 | - |
| 389 | IKNA | Ikena Oncology, Inc. | 64.18M | -0.75% | 6,717 | - |
| 390 | CLSD | Clearside Biomedical, Inc. | 64.11M | -1.79% | 29,257 | 3.76M |
| 391 | MNOV | MediciNova, Inc. | 63.88M | -2.81% | 1,026 | - |
| 392 | IMMX | Immix Biopharma, Inc. | 63.50M | 2.93% | 80,794 | - |
| 393 | ADAP | Adaptimmune Therapeutics plc | 62.87M | -6.25% | 627,943 | 179.64M |
| 394 | MGX | Metagenomi, Inc. | 61.31M | 5.13% | 181,462 | 45.26M |
| 395 | IRD | Opus Genetics, Inc. | 60.56M | 4.62% | 8,608,699 | 13.65M |
| 396 | RENB | Renovaro Inc. | 60.43M | -1.85% | 248,895 | - |
| 397 | ONCY | Oncolytics Biotech Inc. | 60.08M | 6.26% | 230,306 | - |
| 398 | RPTX | Repare Therapeutics Inc. | 59.83M | 1.82% | 8,444 | 1.07M |
| 399 | CRVO | CervoMed Inc. | 59.83M | 0.81% | 16,199 | 9.31M |
| 400 | SER | Serina Therapeutics, Inc. | 59.31M | 0.51% | 541 | 51.00K |
| 401 | NRXP | NRx Pharmaceuticals, Inc. | 59.30M | 4.89% | 89,772 | - |
| 402 | ANEB | Anebulo Pharmaceuticals, Inc. | 59.16M | -2.04% | 1,592 | - |
| 403 | VTGN | Vistagen Therapeutics, Inc. | 58.90M | -0.49% | 28,139 | 486.00K |
| 404 | ICCC | ImmuCell Corporation | 58.74M | 5.86% | 6,376 | 27.30M |
| 405 | GANX | Gain Therapeutics, Inc. | 58.52M | 1.54% | 163,884 | - |
| 406 | CUE | Cue Biopharma, Inc. | 57.27M | -3.30% | 63,220 | 7.99M |
| 407 | ANL | Adlai Nortye Ltd. | 57.20M | -5.48% | 940 | 1.94M |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 57.15M | 0.92% | 28,380 | - |
| 409 | CNTX | Context Therapeutics Inc. | 56.22M | -4.29% | 62,588 | - |
| 410 | IFRX | InflaRx N.V. | 54.99M | -3.37% | 26,266 | 140.24K |
| 411 | GNTA | Genenta Science S.p.A. | 54.87M | -3.23% | 11,022 | - |
| 412 | FBIO | Fortress Biotech, Inc. | 54.70M | 2.78% | 27,403 | 57.78M |
| 413 | VRCA | Verrica Pharmaceuticals Inc. | 54.60M | -1.62% | 9,790 | 7.18M |
| 414 | SNTI | Senti Biosciences, Inc. | 54.24M | 1.44% | 23,073 | - |
| 415 | CNTB | Connect Biopharma Holdings Limited | 53.68M | 1.45% | 14,984 | 26.03M |
| 416 | HOWL | Werewolf Therapeutics, Inc. | 53.62M | - | 29,942 | 1.14M |
| 417 | ACET | Adicet Bio, Inc. | 53.44M | -1.81% | 141,295 | - |
| 418 | ATHE | Alterity Therapeutics Limited | 53.32M | 3.17% | 50,494 | 2.30M |
| 419 | TELO | Telomir Pharmaceuticals, Inc. | 51.94M | -1.97% | 18,433 | - |
| 420 | MAIA | MAIA Biotechnology, Inc. | 51.52M | 1.19% | 103,814 | - |
| 421 | AVTX | Avalo Therapeutics, Inc. | 51.43M | -0.84% | 5,540 | 441.00K |
| 422 | OSTX | OS Therapies Incorporated | 51.42M | 3.98% | 114,400 | - |
| 423 | ADVM | Adverum Biotechnologies, Inc. | 51.18M | -5.04% | 19,777 | 1.00M |
| 424 | STTK | Shattuck Labs, Inc. | 50.54M | 0.48% | 15,822 | 4.61M |
| 425 | APLT | Applied Therapeutics, Inc. | 49.01M | -7.43% | 625,407 | 265.00K |
| 426 | ATRA | Atara Biotherapeutics, Inc. | 48.64M | 1.75% | 4,649 | 199.73M |
| 427 | RNXT | RenovoRx, Inc. | 48.64M | -3.62% | 5,976 | 240.00K |
| 428 | IPSC | Century Therapeutics, Inc. | 48.26M | -1.09% | 203,562 | 114.90M |
| 429 | ATNM | Actinium Pharmaceuticals, Inc. | 48.04M | -6.67% | 74,189 | 81.00K |
| 430 | PRLD | Prelude Therapeutics Incorporated | 47.99M | -0.56% | 18,238 | 7.00M |
| 431 | KLRS | Kalaris Therapeutics, Inc. | 47.50M | -2.31% | 1,728 | - |
| 432 | NRSN | NeuroSense Therapeutics Ltd. | 47.02M | -10.91% | 314,299 | - |
| 433 | DTIL | Precision BioSciences, Inc. | 46.46M | -1.18% | 143,393 | 51.14M |
| 434 | ALGS | Aligos Therapeutics, Inc. | 45.65M | -2.16% | 16,955 | 3.27M |
| 435 | CELU | Celularity Inc. | 44.31M | -1.60% | 39,152 | 54.22M |
| 436 | IPA | ImmunoPrecise Antibodies Ltd. | 44.30M | 3.83% | 193,895 | 16.58M |
| 437 | ANVS | Annovis Bio, Inc. | 44.04M | -1.31% | 241,874 | - |
| 438 | PEPG | PepGen Inc. | 43.19M | -2.94% | 22,805 | - |
| 439 | MURA | Mural Oncology plc | 42.31M | -0.41% | 12,900 | - |
| 440 | MRSN | Mersana Therapeutics, Inc. | 42.20M | -3.45% | 530,806 | 34.01M |
| 441 | GRCE | Grace Therapeutics, Inc. | 41.43M | 1.22% | 9,135 | - |
| 442 | ITRM | Iterum Therapeutics plc | 41.20M | - | 144,400 | - |
| 443 | PLUR | Pluri Inc. | 41.02M | -1.20% | 19,762 | 1.03M |
| 444 | ACRV | Acrivon Therapeutics, Inc. | 40.76M | -2.26% | 97,628 | - |
| 445 | EYEN | Eyenovia, Inc. | 40.22M | -17.49% | 1,231,345 | 67.06K |
| 446 | ARTV | Artiva Biotherapeutics, Inc. | 38.98M | - | 38,907 | 251.00K |
| 447 | KPTI | Karyopharm Therapeutics Inc. | 38.10M | -1.78% | 25,574 | 142.13M |
| 448 | AKTX | Akari Therapeutics, Plc | 37.97M | 1.72% | 17,585 | - |
| 449 | XCUR | Exicure, Inc. | 37.40M | 2.96% | 3,827 | 500.00K |
| 450 | PYPD | PolyPid Ltd. | 37.25M | -2.27% | 25,943 | - |
| 451 | KLTO | Klotho Neurosciences, Inc. | 37.21M | -8.40% | 1,220,526 | - |
| 452 | BRNS | Barinthus Biotherapeutics plc | 36.71M | 2.11% | 1,379 | 14.97M |
| 453 | ABVC | ABVC BioPharma, Inc. | 36.24M | 5.19% | 148,195 | 508.38K |
| 454 | JUNS | Jupiter Neurosciences, Inc. | 35.42M | -4.46% | 28,869 | - |
| 455 | RADX | Radiopharm Theranostics Limited | 35.31M | -1.83% | 7,688 | 204.61K |
| 456 | XLO | Xilio Therapeutics, Inc. | 34.71M | -1.77% | 95,010 | 9.27M |
| 457 | LVTX | LAVA Therapeutics N.V. | 34.59M | 0.05% | 124 | 4.99M |
| 458 | OKUR | OnKure Therapeutics, Inc. | 34.59M | - | 5,784 | - |
| 459 | RNTX | Rein Therapeutics Inc. | 34.14M | 0.06% | 2,599 | - |
| 460 | LTRN | Lantern Pharma Inc. | 34.13M | 1.77% | 11,530 | - |
| 461 | ANTX | AN2 Therapeutics, Inc. | 32.89M | -0.91% | 12,259 | - |
| 462 | ESLA | Estrella Immunopharma, Inc. | 32.60M | -3.12% | 2,309 | - |
| 463 | KZR | Kezar Life Sciences, Inc. | 31.20M | 4.40% | 36,163 | - |
| 464 | KALA | KALA BIO, Inc. | 30.33M | - | 4,376 | - |
| 465 | INKT | MiNK Therapeutics, Inc. | 30.25M | - | 40 | - |
| 466 | CAMP | Camp4 Therapeutics Corporation | 30.03M | -4.49% | 14,690 | 1.51M |
| 467 | DYAI | Dyadic International, Inc. | 29.79M | 0.70% | 841 | 3.55M |
| 468 | ENLV | Enlivex Therapeutics Ltd. | 29.13M | -2.39% | 33,246 | - |
| 469 | TPST | Tempest Therapeutics, Inc. | 29.06M | -0.56% | 20,551 | - |
| 470 | MLEC | Moolec Science SA | 28.89M | - | 830 | 7.83M |
| 471 | RANI | Rani Therapeutics Holdings, Inc. | 28.77M | -1.19% | 55,106 | 1.20M |
| 472 | COEP | Coeptis Therapeutics Holdings, Inc. | 28.36M | -1.59% | 18,868 | 62.87K |
| 473 | VYNE | VYNE Therapeutics Inc. | 27.66M | 21.17% | 2,523,576 | 605.00K |
| 474 | FBLG | FibroBiologics, Inc. | 27.48M | -2.79% | 83,777 | - |
| 475 | PBM | Psyence Biomedical Ltd. | 26.82M | 1.83% | 3,323 | - |
| 476 | GDTC | CytoMed Therapeutics Limited | 26.25M | -2.78% | 5,139 | 368.84K |
| 477 | PULM | Pulmatrix, Inc. | 25.13M | 0.58% | 2,751 | 1.92M |
| 478 | NRXS | NeurAxis, Inc. | 25.03M | 1.84% | 26,143 | 2.93M |
| 479 | OSRH | OSR Holdings, Inc. | 24.67M | 2.40% | 21,816 | -148.95K |
| 480 | IGC | IGC Pharma, Inc. | 24.52M | 0.07% | 28,204 | 1.24M |
| 481 | GBIO | Generation Bio Co. | 24.15M | -1.23% | 60,532 | 24.56M |
| 482 | ALXO | ALX Oncology Holdings Inc. | 23.97M | -2.01% | 47,378 | - |
| 483 | BCAB | BioAtla, Inc. | 23.95M | 0.96% | 146,981 | 11.00M |
| 484 | BOLD | Boundless Bio, Inc. | 23.73M | -0.93% | 71,613 | - |
| 485 | DARE | Daré Bioscience, Inc. | 23.10M | -1.14% | 14,421 | 25.91K |
| 486 | CRIS | Curis, Inc. | 23.07M | 1.61% | 9,672 | 11.20M |
| 487 | CMMB | Chemomab Therapeutics Ltd. | 23.06M | 0.27% | 14,620 | - |
| 488 | OVID | Ovid Therapeutics Inc. | 22.91M | 2.45% | 355,954 | 548.00K |
| 489 | ELEV | Elevation Oncology, Inc. | 22.55M | 0.11% | 58,499 | - |
| 490 | FGEN | FibroGen, Inc. | 21.83M | -5.43% | 14,984 | 7.00M |
| 491 | LSTA | Lisata Therapeutics, Inc. | 21.67M | - | 17,391 | 1.00M |
| 492 | CALC | CalciMedica, Inc. | 20.82M | -5.10% | 58,088 | - |
| 493 | PASG | Passage Bio, Inc. | 20.55M | 1.41% | 107,466 | - |
| 494 | SLGL | Sol-Gel Technologies Ltd. | 20.54M | -1.54% | 2,542 | 12.10M |
| 495 | BLRX | BioLineRx Ltd. | 20.26M | -3.90% | 33,108 | 22.34M |
| 496 | APUS | Apimeds Pharmaceuticals US, Inc. | 20.18M | 5.01% | 3,226 | - |
| 497 | CVKD | Cadrenal Therapeutics, Inc. | 20.16M | -0.97% | 7,191 | - |
| 498 | RLMD | Relmada Therapeutics, Inc. | 19.91M | 11.90% | 240,896 | - |
| 499 | BCTX | BriaCell Therapeutics Corp. | 19.76M | 3.41% | 111,294 | - |
| 500 | CASI | CASI Pharmaceuticals, Inc. | 19.68M | -1.93% | 8,352 | 31.37M |
| 501 | LGVN | Longeveron Inc. | 19.66M | 3.15% | 59,008 | 2.23M |
| 502 | PSTV | Plus Therapeutics, Inc. | 19.30M | 20.16% | 129,743,721 | 5.21M |
| 503 | NNVC | NanoViricides, Inc. | 19.29M | -14.29% | 272,121 | - |
| 504 | CGTX | Cognition Therapeutics, Inc. | 19.12M | 2.80% | 242,326 | - |
| 505 | BIVI | BioVie Inc. | 18.91M | -0.97% | 43,283 | - |
| 506 | QTTB | Q32 Bio Inc. | 18.78M | -1.28% | 25,262 | - |
| 507 | LYRA | Lyra Therapeutics, Inc. | 18.61M | 14.15% | 19,653 | 1.19M |
| 508 | LSB | LakeShore Biopharma Co., Ltd | 18.13M | -1.04% | 22,797 | 79.42M |
| 509 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 18.04M | -49.46% | 12,530,857 | - |
| 510 | MEIP | MEI Pharma, Inc. | 17.68M | 8.31% | 23,921 | - |
| 511 | IMNN | Imunon, Inc. | 17.62M | -1.04% | 471,884 | - |
| 512 | LPCN | Lipocine Inc. | 17.28M | - | 1,971 | 3.67M |
| 513 | CING | Cingulate Inc. | 17.15M | -1.70% | 38,349 | - |
| 514 | CARM | Carisma Therapeutics, Inc. | 16.97M | -0.22% | 414,712 | 19.96M |
| 515 | SABS | SAB Biotherapeutics, Inc. | 16.82M | -0.55% | 3,009 | 377.84K |
| 516 | MRKR | Marker Therapeutics, Inc. | 16.75M | -0.64% | 13,079 | 5.70M |
| 517 | LEXX | Lexaria Bioscience Corp. | 16.44M | -3.47% | 45,961 | 525.92K |
| 518 | EVAX | Evaxion A/S | 16.27M | -0.53% | 142,329 | 3.29M |
| 519 | CLGN | CollPlant Biotechnologies Ltd. | 16.27M | -2.41% | 21,954 | 2.47M |
| 520 | HOOK | HOOKIPA Pharma Inc. | 15.97M | - | 1,920 | 9.35M |
| 521 | PMN | ProMIS Neurosciences, Inc. | 15.94M | 0.56% | 195 | - |
| 522 | COCP | Cocrystal Pharma, Inc. | 15.86M | 2.57% | 2,806 | - |
| 523 | HOTH | Hoth Therapeutics, Inc. | 15.59M | -0.84% | 95,355 | - |
| 524 | CANF | Can-Fite BioPharma Ltd. | 15.03M | - | 9,409 | 674.00K |
| 525 | RLYB | Rallybio Corporation | 14.56M | -0.14% | 115,505 | 848.00K |
| 526 | ALLR | Allarity Therapeutics, Inc. | 14.33M | -4.04% | 149,122 | - |
| 527 | EDSA | Edesa Biotech, Inc. | 14.12M | 0.25% | 156 | - |
| 528 | CTXR | Citius Pharmaceuticals, Inc. | 14.08M | 5.00% | 238,957 | - |
| 529 | SYBX | Synlogic, Inc. | 14.04M | - | - | 8.00K |
| 530 | UBX | Unity Biotechnology, Inc. | 14.01M | 3.21% | 17,226 | - |
| 531 | ASBP | Aspire Biopharma Holdings, Inc. | 13.83M | 18.03% | 40,640,066 | - |
| 532 | NEUP | Neuphoria Therapeutics Inc. | 13.72M | 4.29% | 32,450 | 15.66M |
| 533 | ERNA | Ernexa Therapeutics Inc. | 13.54M | -2.13% | 22,906 | 535.00K |
| 534 | MTVA | MetaVia Inc. | 13.42M | 0.84% | 7,848 | - |
| 535 | ABP | Abpro Holdings, Inc. | 13.35M | 1.20% | 1,000,731 | 183.00K |
| 536 | NXTC | NextCure, Inc. | 13.16M | 0.62% | 70,945 | - |
| 537 | CLRB | Cellectar Biosciences, Inc. | 13.16M | -8.56% | 103,535 | - |
| 538 | ACXP | Acurx Pharmaceuticals, Inc. | 13.15M | -1.15% | 310,144 | - |
| 539 | CVM | CEL-SCI Corporation | 12.68M | 2.49% | 8,260 | - |
| 540 | BRTX | BioRestorative Therapies, Inc. | 12.46M | 0.59% | 4,465 | 391.00K |
| 541 | NERV | Minerva Neurosciences, Inc. | 12.45M | -2.15% | 405 | - |
| 542 | GOVX | GeoVax Labs, Inc. | 12.44M | 0.26% | 163,880 | 5.59M |
| 543 | EVGN | Evogene Ltd. | 12.33M | -4.41% | 38,710 | 6.77M |
| 544 | ATHA | Athira Pharma, Inc. | 12.07M | -0.95% | 72,513 | - |
| 545 | PHGE | BiomX Inc. | 12.04M | -3.95% | 7,114 | - |
| 546 | BTAI | BioXcel Therapeutics, Inc. | 11.99M | -3.41% | 989,819 | 1.85M |
| 547 | APVO | Aptevo Therapeutics Inc. | 11.90M | -0.93% | 120,775 | - |
| 548 | EQ | Equillium, Inc. | 11.79M | -1.14% | 57,208 | 30.41M |
| 549 | BCDA | BioCardia, Inc. | 11.75M | 0.89% | 10,758 | 3.00K |
| 550 | IBIO | iBio, Inc. | 11.73M | -0.96% | 1,254,334 | 375.00K |
| 551 | GTBP | GT Biopharma, Inc. | 11.68M | 10.42% | 65,565 | - |
| 552 | XFOR | X4 Pharmaceuticals, Inc. | 11.66M | -4.50% | 79,706 | 31.36M |
| 553 | LPTX | Leap Therapeutics, Inc. | 11.39M | -2.62% | 285,100 | - |
| 554 | PHIO | Phio Pharmaceuticals Corp. | 10.99M | 5.53% | 105,397 | - |
| 555 | IBO | Impact BioMedical Inc. | 10.97M | -5.58% | 1,116,653 | - |
| 556 | XTLB | XTL Biopharmaceuticals Ltd. | 10.86M | -5.01% | 2,272 | 451.00K |
| 557 | BOLT | Bolt Biotherapeutics, Inc. | 10.77M | 0.18% | 1,910 | 3.64M |
| 558 | CSCI | COSCIENS Biopharma Inc. | 10.53M | -6.57% | - | 9.03M |
| 559 | KAPA | Kairos Pharma, Ltd. | 10.31M | -3.04% | 152,182 | - |
| 560 | SNSE | Sensei Biotherapeutics, Inc. | 10.11M | -6.69% | 3,050 | - |
| 561 | PRTG | Portage Biotech Inc. | 9.51M | -5.40% | 53,780 | - |
| 562 | IMRN | Immuron Limited | 9.44M | -1.07% | 4,788 | 4.05M |
| 563 | CYCN | Cyclerion Therapeutics, Inc. | 9.36M | -1.87% | 756 | 2.08M |
| 564 | KPRX | Kiora Pharmaceuticals, Inc. | 9.22M | - | 10,717 | 20.00K |
| 565 | APRE | Aprea Therapeutics, Inc. | 9.18M | -7.78% | 16,362 | 1.28M |
| 566 | DWTX | Dogwood Therapeutics, Inc. | 9.14M | -0.31% | 3,158 | - |
| 567 | BCLI | Brainstorm Cell Therapeutics Inc. | 8.89M | -5.10% | 205,374 | - |
| 568 | AEON | AEON Biopharma, Inc. | 8.79M | 3.25% | 134,381 | - |
| 569 | CYCC | Cyclacel Pharmaceuticals, Inc. | 8.15M | 0.08% | 190,286 | 14.00K |
| 570 | NLSP | NLS Pharmaceutics AG | 7.99M | 6.75% | 371,308 | - |
| 571 | TSBX | Turnstone Biologics Corp. | 7.87M | -6.34% | 90,906 | - |
| 572 | CHRO | Channel Therapeutics Corporation | 7.65M | -1.69% | 18,112 | - |
| 573 | INTS | Intensity Therapeutics, Inc. | 7.65M | 3.81% | 67,861 | - |
| 574 | TRAW | Traws Pharma, Inc. | 7.62M | -3.52% | 17,334 | 227.00K |
| 575 | ADXN | Addex Therapeutics Ltd | 7.47M | -4.04% | 308 | 278.51K |
| 576 | HCWB | HCW Biologics Inc. | 7.37M | -4.94% | 183,245 | 1.45M |
| 577 | CLDI | Calidi Biotherapeutics, Inc. | 7.34M | -4.79% | 456,894 | - |
| 578 | INAB | IN8bio, Inc. | 7.34M | -2.29% | 32,301 | - |
| 579 | TCRT | Alaunos Therapeutics, Inc. | 7.28M | -1.55% | 3,538 | 11.00K |
| 580 | KZIA | Kazia Therapeutics Limited | 7.21M | -2.12% | 2,353 | 1.55M |
| 581 | APLM | Apollomics, Inc. | 7.17M | 7.05% | 272 | 198.00K |
| 582 | PMCB | PharmaCyte Biotech, Inc. | 7.08M | 0.01% | 872 | - |
| 583 | APM | Aptorum Group Limited | 7.07M | -1.07% | 6,831 | - |
| 584 | CELZ | Creative Medical Technology Holdings, Inc. | 7.02M | 0.06% | 52,890 | 14.00K |
| 585 | GNPX | Genprex, Inc. | 6.98M | 6.46% | 1,046,941 | - |
| 586 | ICU | SeaStar Medical Holding Corporation | 6.94M | 1.65% | 4,009,625 | 428.00K |
| 587 | PPBT | Purple Biotech Ltd | 6.82M | -0.21% | 15,976 | - |
| 588 | SLXN | Silexion Therapeutics Corp | 6.65M | -1.31% | 118,297 | - |
| 589 | PCSA | Processa Pharmaceuticals, Inc. | 6.57M | -4.57% | 3,196,663 | - |
| 590 | RNAZ | TransCode Therapeutics, Inc. | 6.55M | 2.61% | 6,283 | - |
| 591 | XBIO | Xenetic Biosciences, Inc. | 6.00M | 0.26% | 156,850 | 2.58M |
| 592 | SNPX | Synaptogenix, Inc. | 5.81M | 10.88% | 83,841 | - |
| 593 | INDP | Indaptus Therapeutics, Inc. | 5.77M | -2.17% | 566,446 | - |
| 594 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.64M | -1.15% | 21,099 | 19.90K |
| 595 | QNRX | Quoin Pharmaceuticals, Ltd. | 5.55M | 0.85% | 1,912 | - |
| 596 | KTTA | Pasithea Therapeutics Corp. | 5.38M | -0.08% | 16,379 | - |
| 597 | ADIL | Adial Pharmaceuticals, Inc. | 5.25M | 35.41% | 166,806,570 | - |
| 598 | TTNP | Titan Pharmaceuticals, Inc. | 5.19M | -1.79% | 4,413 | - |
| 599 | MTNB | Matinas BioPharma Holdings, Inc. | 4.76M | -3.01% | 46,877 | - |
| 600 | ATNF | 180 Life Sciences Corp. | 4.72M | -5.77% | 59,063 | - |
| 601 | CMND | Clearmind Medicine Inc. | 4.62M | - | 1,835 | - |
| 602 | CNSP | CNS Pharmaceuticals, Inc. | 4.57M | 4.70% | 32,473 | - |
| 603 | SILO | Silo Pharma, Inc. | 4.54M | -2.04% | 74,174 | 72.10K |
| 604 | MBIO | Mustang Bio, Inc. | 4.51M | 0.10% | 10,146 | - |
| 605 | GLTO | Galecto, Inc. | 4.50M | -0.87% | 1,719 | - |
| 606 | AZTR | Azitra, Inc. | 4.45M | 1.22% | 203,015 | 7.50K |
| 607 | THAR | Tharimmune, Inc. | 4.44M | 0.60% | 34,607 | - |
| 608 | CERO | CERo Therapeutics Holdings, Inc. | 4.42M | 2.23% | 112,371 | - |
| 609 | MBRX | Moleculin Biotech, Inc. | 4.38M | 5.23% | 23,265,377 | - |
| 610 | SNGX | Soligenix, Inc. | 4.34M | -1.48% | 39,667 | 2.34K |
| 611 | GLMD | Galmed Pharmaceuticals Ltd. | 4.02M | -1.66% | 68,174 | - |
| 612 | VIVS | VivoSim Labs, Inc. | 3.95M | -1.46% | 7,149 | 144.00K |
| 613 | DRMA | Dermata Therapeutics, Inc. | 3.85M | -3.50% | 71,712 | - |
| 614 | JAGX | Jaguar Health, Inc. | 3.77M | -2.57% | 66,258 | 11.55M |
| 615 | ADTX | Aditxt, Inc. | 3.75M | 8.59% | 1,079,732 | 55.32K |
| 616 | PLRZ | Polyrizon Ltd. | 3.73M | -4.11% | 86,809 | - |
| 617 | VRAX | Virax Biolabs Group Limited | 3.68M | 11.41% | 2,688 | 84.87K |
| 618 | ARTL | Artelo Biosciences, Inc. | 3.65M | 8.98% | 5,393 | - |
| 619 | ENSC | Ensysce Biosciences, Inc. | 3.62M | 0.92% | 10,502 | 6.22M |
| 620 | TOVX | Theriva Biologics, Inc. | 3.55M | 0.79% | 36,271 | - |
| 621 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 3.55M | -0.88% | 18,250 | 1.00M |
| 622 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.53M | -5.14% | 18,746 | 802.32K |
| 623 | SPRC | SciSparc Ltd. | 3.45M | -4.00% | 98,245 | 1.31M |
| 624 | PALI | Palisade Bio, Inc. | 3.36M | -3.39% | 35,560 | - |
| 625 | NBY | NovaBay Pharmaceuticals, Inc. | 3.35M | 0.35% | 1,172 | 9.78M |
| 626 | ZVSA | ZyVersa Therapeutics, Inc. | 3.18M | -6.27% | 537,645 | - |
| 627 | XRTX | XORTX Therapeutics Inc. | 3.04M | 1.60% | 21,575 | - |
| 628 | ENVB | Enveric Biosciences, Inc. | 3.04M | -0.81% | 17,626 | - |
| 629 | ELAB | PMGC Holdings Inc. | 2.96M | 0.94% | 7,070 | 2.45M |
| 630 | GRI | GRI Bio, Inc. | 2.93M | -7.40% | 154,293 | - |
| 631 | OGEN | Oragenics, Inc. | 2.62M | 5.78% | 8,079 | - |
| 632 | QLGN | Qualigen Therapeutics, Inc. | 2.55M | 0.53% | 1,470 | - |
| 633 | BDRX | Biodexa Pharmaceuticals Plc | 2.54M | -3.30% | 70,878 | 104.90K |
| 634 | ONCO | Onconetix, Inc. | 2.38M | 6.54% | 90,790 | 1.93M |
| 635 | CDT | Conduit Pharmaceuticals Inc. | 2.32M | -0.41% | 115,704 | - |
| 636 | PTIX | Protagenic Therapeutics, Inc. | 2.29M | 6.28% | 321,050 | - |
| 637 | SCNI | Scinai Immunotherapeutics Ltd. | 2.26M | -3.97% | 11,095 | 658.00K |
| 638 | ENTO | Entero Therapeutics, Inc. | 2.24M | 1.82% | 58,945 | - |
| 639 | SLRX | Salarius Pharmaceuticals, Inc. | 2.11M | -6.60% | 127,947 | - |
| 640 | ALZN | Alzamend Neuro, Inc. | 2.06M | -3.10% | 83,413 | - |
| 641 | REVB | Revelation Biosciences, Inc. | 1.99M | 16.81% | 375,709 | - |
| 642 | LIXT | Lixte Biotechnology Holdings, Inc. | 1.96M | -6.29% | 29,314 | - |
| 643 | TNFA | TNF Pharmaceuticals, Inc. | 1.83M | -6.18% | 1,268,460 | - |
| 644 | WINT | Windtree Therapeutics, Inc. | 1.47M | 8.65% | 1,687,914 | - |
| 645 | NCNA | NuCana plc | 510.00K | -4.86% | 10,057,617 | - |